|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
218,850,000 |
Market
Cap: |
39.94(B) |
Last
Volume: |
90,505,923 |
Avg
Vol: |
10,608,554 |
52
Week Range: |
$182.5 - $182.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mackay Martin |
EVP & Global Head of R&D |
|
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
51,058 |
|
- |
|
Mackay Martin |
EVP & Global Head of R&D |
|
2017-02-28 |
4 |
S |
$131.70 |
$82,313 |
D/D |
(625) |
38,258 |
|
- |
|
Wagner Heidi L |
SVP, Global Government Affairs |
|
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,400 |
33,410 |
|
- |
|
Wagner Heidi L |
SVP, Global Government Affairs |
|
2017-02-28 |
4 |
S |
$131.70 |
$63,216 |
D/D |
(480) |
29,166 |
|
- |
|
Thiel Carsten |
EVP, Chief Commercial Officer |
|
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
37,643 |
|
- |
|
Thiel Carsten |
EVP, Chief Commercial Officer |
|
2017-02-28 |
4 |
S |
$0.00 |
$0 |
D/D |
(54) |
30,143 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
39,565 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2017-02-28 |
4 |
S |
$131.71 |
$120,515 |
D/D |
(915) |
33,065 |
|
- |
|
Bell Leonard |
Director |
|
2017-02-28 |
4 |
S |
$131.71 |
$360,622 |
D/D |
(2,738) |
391,910 |
|
- |
|
Miller Edward |
SVP, Chief Compliance Officer |
|
2017-02-27 |
4 |
S |
$131.20 |
$34,112 |
D/D |
(260) |
15,214 |
|
- |
|
Moriarty John B |
EVP & General Counsel |
|
2017-02-27 |
4 |
S |
$131.20 |
$80,294 |
D/D |
(612) |
45,864 |
|
- |
|
Oneill Julie |
EVP. Global Operations |
|
2017-02-27 |
4 |
S |
$131.20 |
$119,392 |
D/D |
(910) |
31,679 |
|
- |
|
Mackay Martin |
EVP & Global Head of R&D |
|
2017-02-27 |
4 |
S |
$131.20 |
$112,832 |
D/D |
(860) |
38,883 |
|
- |
|
Wagner Heidi L |
SVP, Global Government Affairs |
|
2017-02-27 |
4 |
S |
$131.20 |
$46,970 |
D/D |
(358) |
29,646 |
|
- |
|
Thiel Carsten |
EVP, Chief Commercial Officer |
|
2017-02-27 |
4 |
S |
$131.20 |
$9,315 |
D/D |
(71) |
30,197 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2017-02-27 |
4 |
S |
$131.20 |
$112,832 |
D/D |
(860) |
33,980 |
|
- |
|
Bell Leonard |
Director |
|
2017-02-09 |
4 |
S |
$126.84 |
$31,203 |
D/D |
(246) |
394,648 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2017-02-09 |
4 |
S |
$126.84 |
$21,182 |
D/D |
(167) |
34,840 |
|
- |
|
Moriarty John B |
EVP & General Counsel |
|
2017-02-09 |
4 |
S |
$126.84 |
$21,182 |
D/D |
(167) |
46,476 |
|
- |
|
Mackay Martin |
EVP & Global Head of R&D |
|
2017-02-09 |
4 |
S |
$126.84 |
$27,524 |
D/D |
(217) |
39,743 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2017-02-07 |
4 |
S |
$128.09 |
$21,263 |
D/D |
(166) |
35,007 |
|
- |
|
Bell Leonard |
Director |
|
2017-02-07 |
4 |
S |
$128.09 |
$129,371 |
D/D |
(1,010) |
394,894 |
|
- |
|
Wagner Heidi L |
SVP, Global Government Affairs |
|
2017-02-07 |
4 |
S |
$128.09 |
$28,436 |
D/D |
(222) |
30,004 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2017-02-06 |
4 |
S |
$125.69 |
$427,872 |
D/D |
(3,404) |
35,173 |
|
- |
|
Bell Leonard |
Director |
|
2017-02-06 |
4 |
S |
$125.69 |
$969,728 |
D/D |
(7,715) |
395,904 |
|
- |
|
1501 Records found
|
|
Page 11 of 61 |
|
|